Health & Biotech
ASX Health Stocks: Imugene gains on positive early signs from Phase 1 trial
PharmAust partners with US-based Berry Consultants for Phase 2/3 study
ASX Health Stocks: Immuron chalks up record half for travelers’ diarrhoea medicine, Travelan
ScoPo’s Powerplays: ASX health stocks feeling the love as Avita Medical kicks off 2024 strongly
ASX Health Stocks: Lumos, Singular, and Imricor all jump today after deals and approvals
Weed Week: Blow to cannabis as Thailand backpedals on weed law; and recent ASX pot stock winners
ASX Health Stocks: Emyria surges 19pc after granting of ‘Authorised Prescriber’ status by TGA
Weed Week: Cannabis stocks down almost 20% in 2023 but ECS Botanics showing resilience
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
ASX Health Stocks: US bound Telix plans dual listing on the NASDAQ
PharmAust just got a pre-IND meeting with the US FDA to kick off ‘24
ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024
ASX Health Stocks: Nova Eye surges over 40pc after USA Medicare changes withdrawn
ASX Health Stocks: More positive data for Recce’s drug, Cynata expects trial results in Q1
Check Up: The reason people quit weight-loss drugs
ASX biotechs with big catalysts in 2024: Part 2
ASX Health Stocks: Opthea up 13pc on $85m funding from giant investment firm Carlyle, new investor
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.